☆ 4.5 Article

Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2

MABS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons

Nischal Ranganath et al.

Summary: In a cohort of 483 high-risk patients treated with nirmatrelvir/ritonavir for COVID-19, 0.4% required hospitalization by day 30. Rebound of symptoms occurred in 0.8% of patients at a median of 9 days after treatment, but all resolved without additional COVID-19-directed therapy.

CLINICAL INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Immunology

Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19)

Julie Boucau et al.

Summary: We enrolled 7 individuals who experienced recurrent symptoms or antigen test conversion after treatment with nirmatrelvir-ritonavir. High viral loads were detected after rebound, lasting a median of 17 days after initial diagnosis. Three individuals had culturable virus for up to 16 days after initial diagnosis. No known resistance-associated mutations were found.

CLINICAL INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants

Anna R. Maekelae et al.

Summary: The authors describe a small antibody-like protein, TriSb92, that can prevent infection by diverse SARS-CoV-2 variants. In cell culture and mice, intranasal treatment with TriSb92 before or shortly after exposure to the virus showed protective effects. This highly manufacturable and stable trimeric antibody-mimetic has the potential to be used as a nasal spray for protecting susceptible individuals from SARS-CoV-2 infection.

NATURE COMMUNICATIONS (2023)

添加到收藏夹

Article Pathology

Progression and Resolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Golden Syrian Hamsters

Kathleen R. Mulka et al.

Summary: The progression of SARS-CoV-2 in a Syrian hamster model provides valuable insights for the development of therapeutic and preventive interventions for COVID-19.

AMERICAN JOURNAL OF PATHOLOGY (2022)

添加到收藏夹

Article Chemistry, Analytical

Biosensor-Enabled Deconvolution of the Avidity-Induced Affinity Enhancement for the SARS-CoV-2 Spike Protein and ACE2 Interaction

Aspen Rene Gutgsell et al.

Summary: Avidity is a common phenomenon employed by nature to achieve high-affinity interactions, while heterogeneity introduced from multivalent binding interactions complicates result analysis. In this study, an SPR-based assay was developed to control the heterogeneity and successfully deconvolute avidity-induced affinity enhancement for the SARS-CoV-2 spike protein and ACE2 interaction.

ANALYTICAL CHEMISTRY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni et al.

Summary: The Omicron variant of SARS-CoV-2 has raised concerns due to its 37 amino acid substitutions in the spike protein, particularly in the receptor-binding domain (RBD), leading to increased binding affinity with human ACE2. Neutralizing activity against Omicron was greatly reduced in convalescent and vaccinated individuals compared to the ancestral virus, but this decrease was less significant after a third vaccine dose. Broadly neutralizing monoclonal antibodies recognizing conserved RBD epitopes may be crucial in combating the Omicron variant and future zoonotic transmissions.

NATURE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants

Lianghui Zhang et al.

Summary: This study demonstrates that engineered ACE2 proteins with augmented binding affinities for SARS-CoV-2 spike protein show broad efficacy against multiple variants, indicating their therapeutic potential.

NATURE CHEMICAL BIOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

Laura A. VanBlargan et al.

Summary: The emergence of the B.1.1.529 Omicron variant raises concerns about the efficacy of antibody countermeasures. This study shows that some of the antibodies currently in clinical use may lose their ability to neutralize the Omicron variant.

NATURE MEDICINE (2022)

添加到收藏夹

Article Immunology

DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster Model

Levi A. Tamming et al.

Summary: SARS-CoV-2 infections pose a significant threat to public health, and vaccines are crucial for prevention. A novel DNA vaccine, incorporating the SARS-CoV-2 spike protein fused with CD40 ligand, demonstrated effective immune responses and reduced pathology in animal studies.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies

Jonathan Z. Li et al.

Summary: Early initiation of antiretroviral therapy can significantly delay the time to HIV rebound after treatment interruption, lowering the barrier for HIV remission.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Review Medicine, Research & Experimental

David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors

Mohamed A. Alfaleh et al.

Summary: Recombinant angiotensin-converting enzyme 2 (rACE2) can be used as a soluble receptor trap to block SARS-CoV-2 infection and limit viral escape potential. The efficacy and antiviral activity of rACE2 can be enhanced through the use of Fc fusions and introducing point mutations.

MABS (2022)

添加到收藏夹

Article Infectious Diseases

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies

Daichi Yamasoba et al.

LANCET INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Multidisciplinary Sciences

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

Yunlong Cao et al.

Summary: Omicron sublineages BA.2.12.1, BA.4 and BA.5 have higher transmissibility and increased evasion of neutralizing antibodies compared to the BA.2 lineage. They exhibit similar binding affinities to the ACE2 receptor as BA.2. BA.1 infection after vaccination boosts humoral immune memory against wild-type SARS-CoV-2, but these antibodies are largely evaded by BA.2 and BA.4/BA.5 variants.

NATURE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent

Tianshu Xiao et al.

Summary: This study introduces a trimeric ACE2 ectodomain variant engineered using a structure-based approach, which has a high binding affinity for the spike protein of SARS-CoV-2, preserved peptidase activity, and the ability to block angiotensin II receptor activation. The engineered ACE2 also shows potent inhibition of SARS-CoV-2 infection in cell culture, suggesting it may be a promising therapeutic agent for COVID-19.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Tyler N. Starr et al.

Summary: Research has found that mutations in the receptor binding domain (RBD) of SARS-CoV-2 may potentially escape the action of the REGN-COV2 cocktail, providing important information for interpreting mutations observed during viral surveillance.

SCIENCE (2021)

添加到收藏夹

Article Microbiology

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

Zhuoming Liu et al.

Summary: The study found that antibodies targeting the SARS-CoV-2 spike protein have escape mutations, different monoclonal antibodies have unique resistance profiles, some mutants are resistant to multiple antibodies while some variants can escape neutralization by convalescent sera. Comparing antibody-mediated mutations with circulating SARS-CoV-2 sequences revealed substitutions that may weaken neutralizing immune responses in some individuals, warranting further investigation.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Microbiology

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

Allison J. Greaney et al.

Summary: The evolution of SARS-CoV-2 may impact the recognition of the virus by human antibody-mediated immunity, with mutations affecting antibody binding varying significantly among individuals and within the same individual over time. Despite this variability, mutations that greatly reduce antibody binding usually occur at specific sites in the RBD, with E484 being the most crucial. These findings can inform surveillance efforts for SARS-CoV-2 evolution in the future.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Medicine, General & Internal

REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19

D. M. Weinreich et al.

Summary: REGEN-COV reduced the risk of Covid-19-related hospitalization or death, resolved symptoms, and reduced the SARS-CoV-2 viral load more rapidly than the placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Pengfei Wang et al.

Summary: The COVID-19 pandemic has had global repercussions, with promising vaccines and monoclonal antibody therapies. However, newly detected variants of SARS-CoV-2 present challenges to these treatment options.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

Kevin R. McCarthy et al.

Summary: The translation above discusses zoonotic pandemics caused by animal viruses spilling over into highly susceptible human populations, specifically focusing on the evolution of coronaviruses in human hosts and the impact of recurrent deletions in the spike glycoprotein on antibody epitopes. These studies help understand the antigenic evolution and adaptive evolution of SARS-CoV-2.

SCIENCE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant

Bassel Akache et al.

Summary: Novel protein subunit vaccine formulations containing resistin-trimerized spike antigen SmT1, combined with SLA archaeosome adjuvant, induced robust immune responses in mice, with strong neutralizing activity against B.1.1.7 and B.1.351 variants. The vaccines were highly efficacious in reducing viral load and body weight loss in a hamster challenge model even after a single vaccination, showing promising potential for development as efficacious protein subunit vaccines for SARS-CoV-2.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Microbiology

Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization

Pengfei Wang et al.

Summary: The emerging Brazilian variant P.1 shows increased resistance to antibody neutralization, posing a threat to current antibody therapies, but has less impact on the effectiveness of protective vaccines.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection

Ami Miller et al.

Summary: A novel protein engineering technology has been used to produce a tetravalent ACE2-Fc-TD protein that effectively blocks SARS-CoV-2 virus infection. This tetrameric protein complex acts as a powerful decoy protein, capable of binding to the virus and preventing its invasion.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections

Hilal Ahmad Parray et al.

Summary: The route of administration plays a crucial role in the success of therapeutic agents, with inhalation being a promising strategy for treating respiratory diseases by providing higher concentrations of drugs in the respiratory airways and overcoming the limitations of systemic administration.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)

添加到收藏夹

Correction Biochemistry & Molecular Biology

Tackling COVID-19 with neutralizing monoclonal antibodies (vol 184, pg 3086, 2021)

Davide Corti et al.

CELL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

Rita E. Chen et al.

Summary: Cell culture experiments showed reduced or abrogated neutralizing activity of monoclonal antibodies against SARS-CoV-2 variant strains, but low prophylactic doses of antibody combinations protected against infection in vivo without resistance emergence. Higher doses of several monoclonal antibody cocktails also provided protection against viruses with a B.1.351 spike gene in vivo. Many antibody products with Emergency Use Authorization should therefore retain substantial efficacy against prevailing variant strains of SARS-CoV-2.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants

Zhiqiang Ku et al.

Summary: A newly engineered IgM neutralizing antibody, IgM-14, demonstrates over 230-fold higher potency in neutralizing SARS-CoV-2 compared to the parental IgG-14. IgM-14 also displays strong neutralizing activity against resistant virus variants and receptor-binding domain mutants, indicating its potential as an effective therapy for COVID-19.

NATURE (2021)

添加到收藏夹

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma

Emanuele Andreano et al.

Summary: Research suggests that SARS-CoV-2 has the potential to generate variants resistant to neutralizing antibodies, and computational modeling predicts that these variants may prevent binding of neutralizing antibodies. Therefore, the development of vaccines and antibodies capable of controlling emerging variants is crucial.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

Matthew McCallum et al.

Summary: The novel CAL.20C (B.1.427/B.1.429) variant carries spike protein mutations, resulting in reduced neutralizing titers in vaccinated individuals and convalescent individuals. The L452R mutation reduces neutralizing activity in RBD-specific monoclonal antibodies, while the S13I and W152C mutations lead to the total loss of neutralization in NTD-specific antibodies due to antigenic supersite remodeling.

SCIENCE (2021)

添加到收藏夹

Article Virology

Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

Sandro Halwe et al.

Summary: DZIF-10c is a highly potent fully human monoclonal neutralizing antibody against SARS-CoV-2, with the ability to effectively neutralize the virus and eliminate infectious particles in the lungs when administered intranasally. Its favorable pharmacokinetic profile makes it a promising candidate for clinical trials investigating topical delivery of anti-SARS-CoV-2 antibodies.

VIRUSES-BASEL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

Allison J. Greaney et al.

Summary: The study found that although the human immune system can produce antibodies that target diverse RBD epitopes, in practice, the polyclonal response to infection tends to be skewed towards a single class of antibodies targeting an epitope that is already undergoing rapid evolution.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants

Shiho Tanaka et al.

Summary: The study identified an ACE2 decoy that can effectively combat SARS-CoV-2 variants, offering a treatment option. The use of MD simulation to predict ACE2 sequence substitutions and screen candidate ACE2 decoys enhances efficacy against variants.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Genetics & Heredity

Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2

Juan Angel Patino-Galindo et al.

Summary: Through phylogenetic and recombination analyses, this study identified evidence of a recombination event in the receptor binding domain (RBD) of both SARS-CoV and SARS-CoV-2, resulting in increased binding affinity to the human ACE2 receptor. Structural modeling suggests that ancestors of SARS-CoV-2 may have acquired the ability to infect humans decades ago, with further mutations in the RBD enhancing binding affinity with the human receptor in SARS-CoV and SARS-CoV-2.

GENOME MEDICINE (2021)

添加到收藏夹

Review Infectious Diseases

A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2

Ramesh Nathan et al.

Summary: This article discusses the guidelines for the use of neutralizing monoclonal antibodies for the treatment of COVID-19, including the characteristics of the drugs, methods of use, and recommendations for handling variants in clinical practice. It also suggests that healthcare professionals should consider the prevalence of resistant variants in their area when developing treatment plans to improve efficacy.

INFECTIOUS DISEASES AND THERAPY (2021)

添加到收藏夹

Review Immunology

Viral targets for vaccines against COVID-19

Lianpan Dai et al.

Summary: The urgent need for vaccines to control the COVID-19 pandemic has led to the rapid development of multiple vaccine candidates, with some showing positive results in late-stage clinical trials. This article discusses the viral elements used in these candidates, the reasons why they are good targets for the immune system, and their implications for protective immunity. Dai and Gao highlight the importance of selecting the right viral targets in vaccine development to ensure an effective immune response and the overall safety and efficacy of the vaccine.

NATURE REVIEWS IMMUNOLOGY (2021)

添加到收藏夹

Letter Cell Biology

Engineered trimeric ACE2 binds viral spike protein and locks it in Three-up conformation to potently inhibit SARS-CoV-2 infection

Liang Guo et al.

CELL RESEARCH (2021)

添加到收藏夹

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

添加到收藏夹

Article Microbiology

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Michael Letko et al.

NATURE MICROBIOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

Yixuan J. Hou et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

Vanessa Monteil et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

添加到收藏夹

Letter Medicine, General & Internal

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Wenling Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig

Changhai Lei et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Biology

SARS-CoV-2 (COVID-19) by the numbers

Yinon M. Bar-On et al.

ELIFE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Qianqian Li et al.

CELL (2020)

添加到收藏夹

Letter Biochemistry & Molecular Biology

Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2-infected Hamsters: What Matters?

Achim D. Gruber et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Luca Piccoli et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Davide F. Robbiani et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

Lars Wallentin et al.

EUROPEAN HEART JOURNAL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2

Kui K. Chan et al.

SCIENCE (2020)

添加到收藏夹

Review Medicine, Research & Experimental

Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination

Ariane Sternberg et al.

LIFE SCIENCES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2

Anum Glasgow et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Multidisciplinary Sciences

REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters

Alina Baum et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

Longxing Cao et al.

SCIENCE (2020)

添加到收藏夹

Article Critical Care Medicine

Human recombinant soluble ACE2 in severe COVID-19

Alexander Zoufaly et al.

LANCET RESPIRATORY MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2

Thomas W. Linsky et al.

SCIENCE (2020)

添加到收藏夹

Review Immunology

Structure, Function, and Therapeutic Use of IgM Antibodies

Bruce A. Keyt et al.

ANTIBODIES (2020)

添加到收藏夹

Article Biology

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Yiska Weisblum et al.

ELIFE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

Lars Wallentin et al.

EUROPEAN HEART JOURNAL (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Predictive Modeling of Influenza Shows the Promise of Applied Evolutionary Biology

Dylan H. Morris et al.

TRENDS IN MICROBIOLOGY (2018)

添加到收藏夹

Article Critical Care Medicine

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

Akram Khan et al.

CRITICAL CARE (2017)

添加到收藏夹

Review Immunology

Exploiting Mucosal Immunity for Antiviral Vaccines

Akiko Iwasaki

ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)

添加到收藏夹

Article Medicine, Research & Experimental

Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding

M. Jack Borrok et al.

MABS (2015)

添加到收藏夹

Article Medicine, Research & Experimental

Improving biophysical properties of a bispecific antibody scaffold to aid developability Quality by molecular design

Thomas Spreter Von Kreudenstein et al.

MABS (2013)

添加到收藏夹

Article Biochemical Research Methods

Chromatographic behavior of IgM:DNA complexes

Pete Gagnon et al.

JOURNAL OF CHROMATOGRAPHY A (2011)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis

Fina Lovren et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

K Kuba et al.

NATURE MEDICINE (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.